Today on in-pharmatechnologist.com
 
Pharma must 'reinvent' itself to survive

Valeritas insulin delivery device gets a name

Pharmaceutical manufacturing: news in brief

Genentech Avastin decision 'hard to overlook'

Future of satraplatin uncertain

 
   
Related Industry News
 
Clinical contract news in brief

Treating cancer as infectious disease yields results

UK updates clinical trial negotiation system to include CROs

Parexel profits perky in Q1

 
 

Pharmaceutical & technology

Breaking News on Pharmaceutical Technology - Europe
Daily  Friday 02 November 2007 Forward to a colleague

Product Presentation

IMAMulti Channel Electronic Counter for Tablets and Capsules

SWIFTPHARM takes electronic counting and bottle filling to higher levels of speed and accuracy and delivers twice the output of existing multi-track counters for a given footprint... Click Here

Access Full Stories



Pharma must 'reinvent' itself to survive
With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent... Read


Valeritas insulin delivery device gets a name
US-based Valeritas has announced the brand name for its lead candidate disposable insulin delivery device - V-Go... Read


Pharmaceutical manufacturing: news in brief
In-PharmaTechnologist.com brings you a selection of other headlines from the pharmaceutical manufacturing industry... Read


Genentech Avastin decision 'hard to overlook'
Despite Genentech's recent decision to push out the cut-off date to ban the sale of cancer drug Avastin (bevacizumab) to compounding pharmacies in the US to restrict off-label use, ophthalmologists still find the... Read


Future of satraplatin uncertain
GPC Biotech has met another obstacle in its path towards satraplatin approval after the German company announced disappointing and unexpected results in its Phase III trial... Read


All News Headlines for:
November | October | September

Product Presentation

Supremely Flexible: Spray Drying from Niro

The new PSD-1 pharmaceutical spray dryer from Niro allows you to perform exacting R&D as well as production of IMP's and small-scale manufacturing with one and the same unit. Drying with the PHARMASD series of spray dryers gives you optimum control of product properties... Click Here

Related Industry News



Clinical contract news in brief
Outsourcing-Pharma.com compiles the news that featured in the clinical contract community this past week, involving PPD, Novotech and Generex... Read


Treating cancer as infectious disease yields results
For the first time, scientists have found a way to target viral antigens deep inside a cancer tumour, and the result is a new therapy that could treat or even prevent the disease... Read


UK updates clinical trial negotiation system to include CROs
An update to the contract negotiation system for hospital-based clinical trials has come into play in the UK - in a further effort to take some of the pain out of the process and speed up trial start-up times... Read


Parexel profits perky in Q1
Parexel has seen its profits remain perky during its first financial quarter of 2008... Read


Weekly Comment

Pfizer partners in shock after surprise Exubera exit

We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find out the product was being scrapped through a press release. Read



RoquetteProduct Presentation

LYCOAT™ for quicker quality coating

Roquette has developed the LYCOAT™ range in response to market requirements for more functional coating solutions in terms of organoleptic properties, solubilisation and process efficiency... Click Here
Previous Headlines



SCOLR on track for first 12-hour ibuprofen
SCOLR Pharma has initiated the first of three pivotal trials to evaluate its extended release ibuprofen tablet, with hopes that it will be the first and only 12-hour formulation on the market... Read


GSK blocks new patent rules
Just a day before they were due to come into force, GlaxoSmithKline has won a court case to block controversial changes to patent rules... Read


Inyx drama highlights crucial need for due diligence on contractors
There are lessons to be learned about the importance of rigorous due diligence of pharma contractors, now that Inyx' customers are facing possible supply issues and a scramble to find alternative manufacturers... Read


Premature ejaculation spray coming to clinical climax
A nifty spray-on solution could make all the difference for men plagued with the problem of climaxing too soon, as the product makes its final thrust in clinical development... Read


Once-weekly diabetes treatment looking good
A once-weekly Type II diabetes treatment has shown promise when compared to its twice-daily counterpart... Read

Product Information - brochures, Web centers
The Safe'n'Sound Passive Safety Device for Prefilled Syringes - Product Presentation

A Review of Dissolution tests with the Flow Through Method - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Cleanroom, safety equipment, supplies
Contract services (outsourcing)
Drug delivery systems
Ingredients, excipients and raw materials
IT solutions
Lab equipment & consumables
Packaging machinery & supplies
Processing (automation, control, separation...)
QA/QC & validation
Tabletting, coating & ancillary equipment




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@In-PharmaTechnologist.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com